Open-Label Extension Study of 23 mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease

Clinical Trial ID NCT00566501

PubWeight™ 1.68‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00566501

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Transdermal donepezil on the treatment of Alzheimer's disease. Neuropsychiatr Dis Treat 2012 0.93
2 Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer's disease. BMC Res Notes 2012 0.78
Next 100